01 1Maprimed
01 1CARIPRAZINE HYDROCHLORIDE
01 1Argentina
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2019-08-14
Pay. Date : 2019-03-15
DMF Number : 33623
Submission : 2019-03-22
Status : Active
Type : II
20
Maprimed Sa, based in Argentina, is a pharmaceutical company.
One of their notable products is CARIPRAZINE HYDROCHLORIDE, with a corresponding US DMF Number 33623.
Remarkably, this DMF maintains an Active status since its submission on March 22, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 14, 2019, and payment made on March 15, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II
